Investor’s Alert: Kandi Technologies Group, Inc. (NASDAQ:KNDI), Therapix Biosciences Ltd. (NASDAQ:TRPX)

0

Kandi Technologies Group, Inc. (NASDAQ:KNDI)

Kandi Technologies Group, Inc. (NASDAQ:KNDI) represented a move of 0 percent or $0.21 per share and closed its previous day trading session at $4.5. 0 Shares were traded in the last trading session with an Average Volume of 500.14 Million Shares. The stock currently has a Market Capitalization of 233.78 Million.

KANDI TECHNOLOGIES, CORP. is a PRC (China)-based vehicle machinery producer, concentrating on three areas of small vehicle production: go-karts, special purpose vehicles and casual purpose vehicles. At present, it is among the leading producers of go-karts in the world, with an estimated 15% share of China’s global export market and a goal of doubling this share, in large part by becoming the leading producer of this increasingly popular recreational product in China. Focusing on the country’s rapid economic development, the Company also sees an increasing need for transportation vehicles for specific purposes, in particular, mini-size pesticide spraying vehicles and mini-service vehicles. Additionally, the Company produces a wide and growing range of All Terrain Vehicles which it believes represent the highest quality vehicles of this type in China, aimed at the export market as well as the rapidly growing market in the PRC.

The stock traded between $3.60 and $8.25 over 1-Year time period showing its price to sales ratio of 2.22. Kandi Technologies Group, Inc. (NASDAQ:KNDI) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-7.01 and 200-Day Simple Moving Average of $-5.58. Its Price to Free Cash Flow is 0 and Price to Book of 1.01.

Analyst’s recommended the stock as 0 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Kandi Technologies Group, Inc. (NASDAQ:KNDI) reported its Actual EPS of $0.05/share. The analysts offering Earnings Estimates for the company were believing that Kandi Technologies Group, Inc. could bring EPS of $0.06/share. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Thus showing an Earnings Surprise of -16.7 Percent.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

In the last trading session, Therapix Biosciences Ltd. (NASDAQ:TRPX) added its value by 0% closing at the price of $5.39. The stock currently has market capitalization of 18.85 Million, with average volume of 292.69 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Therapix Biosciences Ltd. (NASDAQ:TRPX) is showing beta of 0. This particular value of beta suggests that Therapix Biosciences Ltd. (NASDAQ:TRPX) has historically moved 0% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Therapix Biosciences Ltd. (NASDAQ:TRPX) is at $-1.56.

The stock currently has RSI of 34.61. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company’s product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.

Therapix Biosciences Ltd. (NASDAQ:TRPX) topped its 52-week high price of $9.30 on 11/05/18 and 52-Week Low Price of $3.00 on 07/16/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 11.72% and monthly volatility of 12.03% respectively.